Your search returned 151 studies. (Get alerts for new studies):
- Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome
Conditions: Albinism - Intestinal Disease - Kidney Disease - Myocardial Disease - Pulmonary Fibrosis
1 Location available
- Study of Mycobacterial Infections
Conditions: Atypical Mycobacterium Infections - Cystic Fibrosis - Job's Syndrome
1 Location available
- Procurement and Analysis of Specimens From Individuals With Pulmonary Fibrosis
Conditions: Pulmonary Fibrosis
1 Location available
- Assess the Antifibrotic Activity of Fuzheng Huayu in Chronic Hepatitis C Patients With Hepatic Fibrosis
Conditions: Chronic Hepatitis C
9 Locations available
- Effects of Pycnogenol on Cardiac Fibrosis and Diastolic Dysfunction in Aged Hypertensive Subjects
Conditions: Cardiac Fibrosis - Diastolic Dysfunction
1 Location available
- Concurrent Single Gene and 24 Chromosome Aneuploidy Preimplantation Genetic Diagnosis (PGD)
Conditions: Any Single Gene Disorder (Cystic Fibrosis, Tay-Sachs)
1 Location available
- Durability of Hypertonic Saline for Enhancing Mucociliary Clearance in Cystic Fibrosis
Conditions: Cystic Fibrosis
1 Location available
- Microaspiration in Pulmonary Fibrosis
Conditions: Idiopathic Pulmonary Fibrosis
1 Location available
- Study of Inhaled Carbon Monoxide to Treat Idiopathic Pulmonary Fibrosis
Conditions: Idiopathic Pulmonary Fibrosis
1 Location available
- A Study to Evaluate the Safety and Efficacy of GS-6624 (Formerly AB0024) in Patients With Idiopathic Pulmonary Fibrosis
Conditions: Idiopathic Pulmonary Fibrosis
7 Locations available
- STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Conditions: Idiopathic Pulmonary Fibrosis (IPF)
1 Location available
- Clinical and Basic Investigations Into Erdheim Chester Disease
Conditions: Myelofibrosis - Gaucher Disease - Pulmonary Fibrosis - Hermansky-Pudlak Syndrome (HPS) - Cancer
1 Location available
- Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis
Conditions: Cystic Fibrosis
2 Locations available
- Role of Genetic Factors in the Development of Lung Disease
Conditions: Cystic Fibrosis - Sarcoidosis - Tuberous Sclerosis - Asthma
2 Locations available
- Genetic Disorders of Mucociliary Clearance in Nontuberculous Mycobacterial Lung Disease
Conditions: Mycobacteria, Atypical - Cystic Fibrosis - Ciliary Disorders - Pseudohypoaldosteronism - Bronchiectasis
1 Location available
- Pennsylvania Idiopathic Pulmonary Fibrosis Research Registry
Conditions: Idiopathic Pulmonary Fibrosis
6 Locations available
- Idiopathic Pulmonary Fibrosis Registry for Future Studies
Conditions: Lung Disease, Interstitial - Idiopathic Pulmonary Fibrosis
1 Location available
- Switching From One Type of Anti-Rejection Drug (Tacrolimus or Cyclosporine) to Another (Sirolimus) Approximately 90-180 Days After Liver Transplantati
Conditions: Side Effects of Calcineurin Inhibitors - Renal Toxicity - Hepatic Fibrosis on Biopsy - Neurotoxicity - Post Transplant Diabetes
1 Location available
- Pomalidomide for Myelofibrosis Patients
Conditions: Polycythemia Vera - Thrombocythemia
1 Location available
- Study of Reduced Intensity Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT) to Treat Hematologic Malignancies and Hematopoietic Failure S
Conditions: Hematologic Neoplasms - Multiple Myeloma - Anemia, Aplastic - Hemoglobinuria, Paroxysmal - Myelofibrosis
1 Location available
- A Pharmacokinetic and Safety Study of IV Gallium Nitrate (Ganite) in Cystic Fibrosis Patients
Conditions: Cystic Fibrosis
2 Locations available
- Beneficial Effects of Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis
Conditions: Idiopathic Pulmonary Fibrosis
1 Location available
- Trial of Doxycycline to Reduce Sputum MMP-9 Activity in Adult Cystic Fibrosis (CF) Patients
Conditions: Cystic Fibrosis
1 Location available
- Molecular Phenotypes for Cystic Fibrosis Lung Disease
Conditions: Cystic Fibrosis - Lung Diseases
1 Location available
- Absorptive Clearance After Inhaled Osmotics in Cystic Fibrosis
Conditions: Cystic Fibrosis
1 Location available
- A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IV PRM151 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Conditions: Idiopathic Pulmonary Fibrosis
2 Locations available
- Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients
Conditions: Pulmonary Fibrosis
23 Locations available
- Gene Modifiers of Cystic Fibrosis Lung Disease
Conditions: Cystic Fibrosis - Lung Diseases
1 Location available
- Microarray Analysis of Gene Expression in Idiopathic Pulmonary Fibrosis (IPF)
Conditions: Pulmonary Fibrosis
1 Location available
- Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome
Conditions: Hermansky-Pudlak Syndrome (HPS) - Pulmonary Fibrosis - Oculocutaneous Albinism - Platelet Storage Pool Deficiency - Metabolic Disease
1 Location available
- A Study of the Natural Progression of Interstitial Lung Disease (ILD)
Conditions: Interstitial Lung Diseases - Idiopathic Pulmonary Fibrosis - Sarcoidosis
1 Location available
- Exercise Training Study for Patients With Cystic Fibrosis
Conditions: Cystic Fibrosis - Self Regulated Exercise
1 Location available
- Corticosteroids Therapy on the Development of Interstitial Fibrosis in Patients With HIV Infection and Mild Pneumocystis Jirovecii Pneumonia (PCP)
Conditions: Pneumocystis Carinii Pneumonia
1 Location available
- Phase II Study of Digitoxin to Treat Cystic Fibrosis
Conditions: Cystic Fibrosis
1 Location available
- Growth Hormone Therapy for Wasting in Cystic Fibrosis
Conditions: Cystic Fibrosis
1 Location available
- FDG-PET Imaging in Young Cystic Fibrosis Patients
Conditions: Cystic Fibrosis
1 Location available
- Prevention of Cystic Fibrosis Diabetes
Conditions: Cystic Fibrosis - Prediabetes
3 Locations available
- Building Adherence to Live With And Navigate my Cystic Fibrosis (CF) Experience
Conditions: Cystic Fibrosis
1 Location available
- Nephrogenic Systemic Fibrosis (NSF): Analysis of Tissue Gadolinium Levels
Conditions: Nephrogenic Systemic Fibrosis - Nephrogenic Fibrosing Dermopathy
1 Location available
- Spironolactone in Adult Congenital Heart Disease
Conditions: Congenital Heart Disease - Heart Failure - Endomyocardial Fibrosis
1 Location available
- Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)
Conditions: Idiopathic Pulmonary Fibrosis
2 Locations available
- Prediction by Ultrasound of the Risk of Hepatic Cirrhosis in Cystic Fibrosis
Conditions: Cystic Fibrosis - Pancreatic Insufficiency
8 Locations available
- Study of the Effect of VX-770 on Hyperpolarized Helium-3 Magnetic Resonance Imaging in Subjects With Cystic Fibrosis and the G551D Mutation
Conditions: Cystic Fibrosis
1 Location available
- The Fibrosis-Lymphedema Continuum in Head and Neck Cancer
Conditions: Head and Neck Neoplasms - Fibrosis - Lymphedema - Cytokines - Polymorphism, Genetic - Depression
1 Location available
- I Change Adherence & Raise Expectations
Conditions: Cystic Fibrosis
19 Locations available
- Safety and Efficacy of QAX576 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Conditions: Idiopathic Pulmonary Fibrosis
6 Locations available
- Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Conditions: Idiopathic Pulmonary Fibrosis
1 Location available
- A Phase 2 Study to Evaluate the Efficacy and Safety of AB0024 in Adults With Myelofibrosis
Conditions: Myelofibrosis
2 Locations available
- HCV/HIV Coinfection: Antiviral Therapy and Fibrosis
Conditions: HIV Infection - Hepatitis C
1 Location available
- Proteogenomic Monitoring and Assessment of Kidney Transplant Recipients
Conditions: Acute Rejection (AR) of Transplanted Kidney - Chronic Allograft Nephropathy (CAN) - Interstitial Fibrosis (IF) - Tubular Atrophy (TA)
1 Location available
- Dabigatran's Effect on Changes in Atrial Fibrosis in Patients With Atrial Fibrillation
Conditions: Atrial Fibrillation
1 Location available
- Segmental Bronchoalveolar Lavage
Conditions: Asthma - Pulmonary Fibrosis
1 Location available
- Role of Toxins in Lung Infections Caused by Pseudomonas Aeruginosa
Conditions: Pseudomonas Infection - Cystic Fibrosis
3 Locations available
- Blood Collection From Individuals With Lung Disease for Genetic Studies
Conditions: Asthma - COPD - Interstitial Lung Disease - Cystic Fibrosis - Lung Cancer
1 Location available
- Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
Conditions: Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Precancerous Condition - Secondary Myelofibrosis
1 Location available
- Using Rheological Methods to Characterize Cystic Fibrosis (CF) Sputum and the Effects of Mucoactive Agents
Conditions: Cystic Fibrosis
1 Location available
- Exercise-Induced Bronchospasm in Cystic Fibrosis
Conditions: Cystic Fibrosis - Bronchospasm
1 Location available
- Aerosolized Hypertonic Xylitol Versus Hypertonic Saline in Cystic Fibrosis (CF) Subjects
Conditions: Cystic Fibrosis
1 Location available
- Microbial Community Composition and Metabolism in Cystic Fibrosis
Conditions: Cystic Fibrosis
1 Location available
- Study of Oral Arsenic Trioxide With or Without Ascorbic Acid in Adults With Myelofibrosis
Conditions: Primary Myelofibrosis
1 Location available
- Phase-3 Double-Blind, Placebo-Controlled Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusio
Conditions: Primary Myelofibrosis
2 Locations available
- Differentiating Outcome Measures in Infants/Young Children With Cystic Fibrosis Utilizing Controlled Ventilation Infant/Young Child Chest CT Scanning
Conditions: Cystic Fibrosis
1 Location available
- A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF)
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Fibrosis - Fibrosis - Interstitial Lung Disease - Lung Diseases, Interstitial
7 Locations available
- Open-label Vitamin D Trial for Patients With Cystic Fibrosis and Allergic Bronchopulmonary Aspergillosis
Conditions: Cystic Fibrosis - Allergic Bronchopulmonary Aspergillosis - A. Fumigatus
2 Locations available
- Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability
Conditions: Emphysema - Chronic Obstructive Pulmonary Disease (COPD) - Cystic Fibrosis - Pulmonary Fibrosis - Bronchiectasis - Sarcoidosis - Pulmonary Hypertension - Alpha-1 Antitrypsin Deficiency
2 Locations available
- Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
Conditions: Asthma - Chronic Obstructive Pulmonary Disease - Interstitial Lung Disease - Cystic Fibrosis - Pulmonary Hypertension
1 Location available
- Bioequivalence Trial of Luitpold Azacitidine Versus Vidaza® in Patients With Myelodysplastic Syndrome, Myelofibrosis, Chronic Myeloid Leukemia or Chro
Conditions: Myelodysplastic Syndrome - Myelofibrosis - Chronic Myeloid Leukemia - Chronic Lymphocytic Leukemia
1 Location available
- Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia
Conditions: Primary Myelofibrosis - Post-Polycythemic Vera Myelofibrosis - Post-Essential Thrombocythemia Myelofibrosis
2 Locations available
- Rituximab in IgG4-related Disease: A Phase 1-2 Trial
Conditions: Retroperitoneal Fibrosis - Autoimmune Pancreatitis - Sialadenitis - Pseudotumor
1 Location available
- Rifaximin to Prevent Recurrent HCV-Related Fibrosis After Liver Transplant
Conditions: Hepatitis C Virus - Liver Transplant Recipient - Recurrent Fibrosis
1 Location available
- Evaluation of Patients With Idiopathic Pulmonary Fibrosis (IPF) Through an IPF Registry
Conditions: Idiopathic Pulmonary Fibrosis
1 Location available
- Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Myelodysplastic Syndromes - Secondary Myelofibrosis
1 Location available
- Tissue Bank for Pulmonary Diseases
Conditions: Cystic Fibrosis
1 Location available
- IGF-1 Therapy in Patients With Cystic Fibrosis
Conditions: Cystic Fibrosis
2 Locations available
- Correlative Biomarker Study in Patients With Myeloproliferative Disorders
Conditions: Myeloproliferative Disease - Myelofibrosis - Idiopathic Myelofibrosis - Essential Thrombocythemia - Polycythemia Vera
6 Locations available
- Natural History of Bronchiectasis
Conditions: Bronchiectasis - Cystic Fibrosis - Autoimmune Disease - Common Variable Immunodeficiency
1 Location available
- Cardiac MRI for Patients Enrolled in INFUSE-AMI
Conditions: Acute Myocardial Infarction - Coronary Artery Disease - Myocardial Fibrosis - Gadolinium - Myocardial Edema
2 Locations available
- Genetic Modifiers of Cystic Fibrosis Related Diabetes
Conditions: Cystic Fibrosis Related Diabetes
1 Location available
- Study of Hypoxia-Activated Prodrug TH-302 to Treat Advanced Leukemias
Conditions: Acute Myelogenous Leukemia - Acute Lymphoblastic Leukemia - Chronic Myelogenous Leukemia - High-risk Myelodysplastic Syndrome - Chronic Lymphocytic Leukemia - Advanced Myelofibrosis
1 Location available
- Study of Yoga as a Therapy for Cystic Fibrosis (CF) Patients
Conditions: Cystic Fibrosis
1 Location available
- A Rapid 10-minute Liver MRI
Conditions: Underlying Liver Disease - Hepatitis - Fibrosis of Liver - Cirrhosis With Suspicion of Liver Cancer - Lesion on a Prior Ultrasound, CT or Outside MRI
1 Location available
- UAB HRFD Core Center: Core A: The Hepato/Renal Fibrocystic Diseases Translational Resource
Conditions: Hepato/Renal Fibrocystic Disease - Autosomal Recessive Polycystic Kidney Disease - Joubert Syndrome - Bardet Biedl Syndrome - Meckel-Gruber Syndrome - Congenital Hepatic Fibrosis - Caroli Syndrome - Oro-Facial-Digital Syndrome Type I - Nephronophithisis -
1 Location available
- Alternative Dosing Strategy of Ruxolitinib in Patients With Myelofibrosis
Conditions: Primary Myelofibrosis - Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase
15 Locations available
- Pilot Study of GS-6624 in the Treatment of Liver Fibrosis
Conditions: Liver Fibrosis
1 Location available
- Pharmacokinetics of Vancomycin for Inhalation in Cystic Fibrosis
Conditions: Cystic Fibrosis - Methicillin-resistant Staphylococcus Aureus
1 Location available
- Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing an Umbilical Cord Blood Transplant for Hematologic C
Conditions: Acute Myeloid Leukemia - Acute Lymphocytic Leukemia - Chronic Myelogenous Leukemia - Myelofibrosis - MDS - Refractory Anemia - Chronic Lymphocytic Leukemia - Prolymphocytic Leukemia - Multiple Myeloma - Non-Hodgkin's Lymphoma - Leukemia - Lymphoma - Multi
1 Location available
- Liver Fibrosis in HIV-Infected Patients With Elevated Liver Enzymes on Antiretroviral Therapy
Conditions: Liver Fibrosis
1 Location available
- Nasal Potential Difference (NPD) for the Diagnosis of Cystic Fibrosis
Conditions: Cystic Fibrosis
1 Location available
- Familial Myeloproliferative Disorders
Conditions: Polycythemia Vera - Essential Thrombocythemia - Idiopathic Myelofibrosis
5 Locations available
- Genetic Modifiers of Cystic Fibrosis (CF) Liver Disease
Conditions: Cystic Fibrosis - Liver Disease
1 Location available
- Clinical and Therapeutic Implications of Fibrosis in Hypertrophic Cardiomyopathy
Conditions: Myocardial Fibrosis - Hypertrophic Cardiomyopathy
1 Location available
- Structure and Function of Salivary Proteins
Conditions: Cystic Fibrosis
1 Location available
- A Linkage and Association Study in Pulmonary Fibrosis
Conditions: Idiopathic Pulmonary Fibrosis - Familial Pulmonary Fibrosis - Idiopathic Interstitial Pneumonia - Familial Interstitial Pneumonia
2 Locations available
- Early Intervention in Cystic Fibrosis Exacerbation
Conditions: Cystic Fibrosis
3 Locations available
- Rehabilitation of Idiopathic Pulmonary Fibrosis (IPF) Patients
Conditions: Idiopathic Pulmonary Fibrosis
1 Location available
- Study in Subjects With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension (PH) Secondary to Idiopathic Pulmonary Fibrosis (IPF) Using In
Conditions: Pulmonary Arterial Hypertension (PAH) - Pulmonary Hypertension-Idiopathic Pulmonary Fibrosis (PH-IPF)
10 Locations available
- Bone Microarchitecture at the Radius: a Pilot Comparison Between Children With Cystic Fibrosis and Healthy Controls
Conditions: Cystic Fibrosis
1 Location available
- A Study of Sweat Testing Using a Quantitative Patch
Conditions: Cystic Fibrosis
1 Location available
- Ruxolitinib (INCB018424) in Subjects With Primary Myelofibrosis, Post Essential Thrombocythemia-myelofibrosis and Post Polycythemia Vera-myelofibrosis
Conditions: Primary Myelofibrosis - Post Essential Thrombocythemia-myelofibrosis - Post Polycythemia Vera-myelofibrosis
34 Locations available
- Baby Observational and Nutritional Study
Conditions: Cystic Fibrosis - Growth Failure
22 Locations available
- Population Pharmacokinetics of Prolonged Infusion Meropenem in Cystic Fibrosis (CF) Children
Conditions: Cystic Fibrosis - Pneumonia - Pseudomonas Aeruginosa Infection
3 Locations available
- Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis
Conditions: Hematopoietic Neoplasm
6 Locations available
- Genetic Analysis of Gray Platelet Syndrome
Conditions: Genetic Linkage - Myelofibrosis
1 Location available
- Rare Genetic Disorders of the Breathing Airways
Conditions: Kartagener Syndrome - Cystic Fibrosis - Pseudohypoaldosteronism - Primary Ciliary Dyskinesia
7 Locations available
- Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)
Conditions: Idiopathic Pulmonary Fibrosis
1 Location available
- Investigating Mucinase Activity in Airway Disease
Conditions: Asthma - Cystic Fibrosis - Smokers
1 Location available
- Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis With Thalidomide
Conditions: Idiopathic Pulmonary Fibrosis - Cough
1 Location available
- Research Tissue Bank
Conditions: Myelofibrosis - Idiopathic Myelofibrosis - Essential Thrombocythemia - Polycythemia Vera
9 Locations available
- Polycythemia Vera, Myelofibrosis and Essential Thrombocythemia: Identification of PV, MF & ET Genes
Conditions: Polycythemia Vera - Essential Thrombocythemia - Myelofibrosis
1 Location available
- CFF Biomarkers of Exacerbation
Conditions: Cystic Fibrosis
5 Locations available
- Oral Docosahexanoic Acid Supplementation in Cystic Fibrosis
Conditions: Cystic Fibrosis
1 Location available
- Effect of Hypertonic Saline on Mucus Clearance in Children Ages 5-12 With Cystic Fibrosis
Conditions: Cystic Fibrosis - Mucociliary Clearance
1 Location available
- Use of Plasmapheresis for Nephrogenic Fibrosing Dermopathy (NFD)/Nephrogenic Systemic Fibrosis (NSF) and Understanding Its Etiology
Conditions: Nephrogenic Fibrosing Dermopathy - Nephrogenic Systemic Fibrosis
1 Location available
- Costimulatory Molecules as Biomarkers in Cystic Fibrosis
Conditions: Cystic Fibrosis
1 Location available
- Aztreonam Lysine for Pseudomonas Infection Eradication Study
Conditions: Cystic Fibrosis
26 Locations available
- Ruxolitinib and Lenalidomide for Patients With Myelofibrosis
Conditions: Myeloproliferative Diseases
1 Location available
- Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways
Conditions: Cystic Fibrosis - Pseudomonas Aeruginosa
9 Locations available
- G551D Observational Study
Conditions: Cystic Fibrosis
29 Locations available
- HIV Accelerated Liver Disease in Uganda
Conditions: Fibrosis
1 Location available
- To Evaluate the Effect of Different Doses of SAR156597 Given to Patients With Idiopathic Pulmonary Fibrosis (IPF)
Conditions: Idiopathic Pulmonary Fibrosis
3 Locations available
- Study of VX-661 Alone and in Combination With VX-770 in Subjects Homozygous to the F508del-CFTR Mutation
Conditions: Cystic Fibrosis
12 Locations available
- Studying Patients With Cystic Fibrosis and Other Pulmonary and Pancreatic Disorders
Conditions: Bronchiectasis - Cystic Fibrosis - Pancreatic Insufficiency
1 Location available
- The Role of Bacteria and Genetic Variations in Cystic Fibrosis
Conditions: Lung Diseases
4 Locations available
- Evaluation of Autosomal Recessive Polycystic Kidney Disease and Congenital Hepatic Fibrosis
Conditions: Autosomal Recessive Polycystic Kidney Disease - Congenital Hepatic Fibrosis - Caroli's Disease - Polycystic Kidney Disease - Joubert Syndrome - Cerebro-Oculo-Renal Syndromes - COACH Syndrome - Senior-Loken Syndrome - Dekaban-Arima Syndrome - Cogan Oculomo
1 Location available
- Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)
Conditions: Pulmonary Fibrosis
1 Location available
- Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases
Conditions: Pulmonary Disease - Oropharyngeal Disease - Lymphangioleiomyomatosis - Pulmonary Fibrosis - Asthma - Sarcoidosis
1 Location available
- Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Secondary Myelofibrosis - Small Intestine Cance
1 Location available
- Race, Ethnicity, and Diffuse Parenchymal Lung Disease
Conditions: Idiopathic Pulmonary Fibrosis - Interstitial Lung Disease - Diffuse Parenchymal Lung Disease
1 Location available
- Explanted Lung Tissues With Pulmonary Fibrosis
Conditions: Pulmonary Fibrosis
1 Location available
- Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA
Conditions: Cystic Fibrosis - Allergic Bronchopulmonary Aspergillosis
1 Location available
- Use of Levemir® Improves Metabolic and Clinical Status in Cystic Fibrosis-related Diabetes (CFRD)
Conditions: Cystic Fibrosis Related Diabetes
1 Location available
- Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in People With Idiopathic Pulmonary Fibrosis
Conditions: Pulmonary Fibrosis
26 Locations available
- Safety and Efficacy of Sildenafil in Cystic Fibrosis (CF) Lung Disease
Conditions: Cystic Fibrosis
1 Location available
- CEP-701 (Lestaurtinib) in Myelofibrosis
Conditions: Myelofibrosis - Essential Thrombocythemia - Polycythemia Vera
7 Locations available
- Transfer Impedance in Cystic Fibrosis
Conditions: Cystic Fibrosis
1 Location available
- Losartan in Treating Patients With Idiopathic Pulmonary Fibrosis
Conditions: Precancerous Condition
1 Location available
- A Study in Myeloproliferative Disorders
Conditions: Myeloproliferative Disorders - Thrombocythemia, Essential - Polycythemia Vera - Primary Myelofibrosis
3 Locations available
- Noninvasive Imaging of Heart Failure: A Pilot Study
Conditions: Magnetic Resonance Imaging - Acquired Heart Disease - Myocardial Fibrosis
1 Location available
- Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
Conditions: Idiopathic Pulmonary Fibrosis
18 Locations available
- TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation
Conditions: Double Cord Blood Transplant - Acute Myelogenous Leukemia - Myelodysplastic Syndrome - Myelofibrosis - Acute Lymphoblastic Leukemia - Chronic Myelocytic Leukemia - Non Hodgkins Lymphoma - Hodgkins Lymphoma - Chronic Lymphocytic Leukemia
1 Location available
- Study of the JAK Inhibitor Ruxolitinib Administered Orally to Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera-Myelofibrosis (PPV-MF)
Conditions: Myelofibrosis
3 Locations available
- Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients II
Conditions: Pulmonary Fibrosis
27 Locations available
- Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)
Conditions: Cystic Fibrosis - Methicillin-resistant Staphylococcus Aureus
9 Locations available
- Inhaled Xylitol Versus Saline in Stable Subjects With Cystic Fibrosis
Conditions: Cystic Fibrosis
2 Locations available
- A Phase 2 Study With IPI-926 in Patients With Myelofibrosis
Conditions: Primary Myelofibrosis - Fibrosis, Bone Marrow
3 Locations available
- Safety Study Evaluating Twice-Daily Administration of CYT387 in Primary Myelofibrosis or Post-Polycythemia Vera or Post-Essential Thrombocythemia Myel
Conditions: Primary Myelofibrosis - Post-Polycythemia Vera - Post-Essential Thrombocythemia Myelofibrosis
3 Locations available
- Inflammatory Response and Tissue Fibrosis/ Lymphatico-venous Bypass
Conditions: Breast Cancer - Genitourinary Cancer - Malignant Female Reproductive System Neoplasm - Melanoma - Sarcoma
1 Location available
- Double-blind Placebo-controlled Pilot Study of Sirolimus in Idiopathic Pulmonary Fibrosis (IPF)
Conditions: Idiopathic Pulmonary Fibrosis - Diffuse Parenchymal Lung Disease - Interstitial Lung Disease
1 Location available
- Imaging Airway Liquid Absorption in Cystic Fibrosis
Conditions: Cystic Fibrosis
1 Location available
- Clinical Evaluation of NeoPlex4 Assay and NeoPlex System
Conditions: Adrenal Hyperplasia, Congenital - Congenital Hypothyroidism - Cystic Fibrosis
3 Locations available
- Detection of Liver Fibrosis With Magnetic Resonance Imaging (MRI)
Conditions: Chronic Liver Disease
1 Location available
|